No Detail Found!

Analysis of factors afecting the clinical eficacy and quality of life in the treatment of pediatric acute lymphoblastic leukemia

Author(s)
Dan Liu Department of Neonatology, Associate Chief Physician, Associate Professor, The First Affiliated Hospital of Yangtze University, Jingzhou 434000, Hubei, China; The First Clinical Medical Collage of Yangtze University, Jingzhou 434000, Hubei, China; The First Affiliated Hospital of Yangtze University, Jingzhou 434000, Hubei, China.
Yi-fei Zhang Department of Pediatric Medicine, Chief Physician, The First Affiliated Hospital of Yangtze University, Jingzhou 434000, Hubei, China.
Abstract
Objective: To analyze the factors afecting the long-term clinical eficacy and quality of life in the treatment of pediatric acute lymphoblastic leukemia (ALL). Methods: This is a retrospective study. One hundred children with ALL were collected before June, 2018 at The First Afiliated Hospital of Yangtze University and followed up for five years. Not only were their five-years survival rates analyzed, but univariate and multivariate analyses were also performed for factors that might afect their five-year survival rates. The MOS 36-Item Short Form of Health Survey (SF-36) was utilized to investigate the surviving children after five years in order to analyze the factors that may afect the quality of life of the children. Results: The five-years survival rate of one hundred children with ALL after treatment was 91.00% (91/100). Univariate and multivariate Logistic regression analyses were performed on the factors that may afect the long-term eficacy of pediatric ALL. The results showed that white blood cell count at first diagnosis, prednisone response test, treatment compliance and recurrence were independent risk factors for the long-term eficacy of pediatric ALL(p<0.05). The SF-36 survey of 91 surviving children after five years showed that prednisone response test and treatment compliance were independent risk factors afecting the quality of life of pediatric ALL (p<0.05). Conclusion: In the initial diagnosis of pediatric ALL, suficient attention and control should be given to the factors that may afect the long-term clinical eficacy and quality of life, and appropriate treatment plans should be adopted. Meanwhile, the treatment compliance of children should be improved during treatment to improve the survival rate and quality of life of pediatric ALL.
Publication Details
Page(s) 956-961
Published Journal: Pakistan Journal of Medical Sciences, Volume: 40, Issue: 5, Year: 2024

Request the full text from PASTIC

Keywords
Children, Quality of life, Children, Acute Lymphoblastic Leukemia, Long-Term, clinical eficacy
0

Citations

0

Downloads

89

Views